74.8 F
Pakistan
Wednesday, April 29, 2026
HomeHealthCIRM Awards Acurastem $7.5 Million In Grant Funding To Advance AS-241 Toward...
Health

CIRM Awards Acurastem $7.5 Million In Grant Funding To Advance AS-241 Toward A First-In-Human Trial For ALS And FTD

muhammadhasan0426@gmail.com
By muhammadhasan0426@gmail.com
0
3

(MENAFN – PR Newswire) PASADENA, Calif. , April 28, 2026 /PRNewswire/ — AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia. ..

Read full story on Menafn

Previous article
Futurhealth Among The First To Offer Eli Lilly’s Oral GLP-1, Orforglipron, Expanding Access To Next-Generation, Non-Injectable Treatment
Next article
Oil prices rise 3% as Iran war stand-off persists
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Load more

Recent Comments

GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.

Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079

© growthpakistan